Antivacular Endothelial Growth Factor Agent and Their Development: Therapeutic Implication in Ocular Dieae Original Reearch Article

Purpoe To provide an overview of angiogenei and vacular endothelial growth factor (VEGF) and dicue the development approach, afety, and efficacy reult of current and emerging anti-VEGF therapie for ocular dieae. Deign Analyi of literature and current clinical trial of antiangiogenic agent for age-related macular degeneration (AMD). Method Literature review. Reult There are everal novel antiangiogenic molecule that target vacular endothelial growth factor and are being ued in the management of AMD. Large cale, Phae III trial have hown promiing reult in improving viion in thi devatating dieae. Concluion Therapie that target VEGF have hown tremendou promie a treatment for AMD.